Contact
searchSearch
HMP Global

Advertisement

Advertisement

ADVERTISEMENT

January 2011 - FRMC

Department

News Connection
Association of Reduced-Function CYP2C19 Alleles and Adverse Outcomes in Patients Treated with Clopidogrel
01/17/2011
In patients presenting with an acute coronary syndrome (ACS), particularly those who are candidates for percutaneous coronary intervention (PCI), clopidogrel has been shown to reduce cardiovascular events. Clopidogrel acts by blocking the...
In patients presenting with an acute coronary syndrome (ACS), particularly those who are candidates for percutaneous coronary intervention (PCI), clopidogrel has been shown to reduce cardiovascular events. Clopidogrel acts by blocking the...
In patients presenting with an...
01/17/2011
First Report Managed Care
Conference Insider
Excessive Daytime Sleepiness Contributes to Medication Nonadherence
01/17/2011
Community-dwelling adults with heart failure (HF) often forget to take their HF medications due to excessive daytime sleepiness, according to a study reported at a poster session during the AHA meeting. 
Community-dwelling adults with heart failure (HF) often forget to take their HF medications due to excessive daytime sleepiness, according to a study reported at a poster session during the AHA meeting. 
Community-dwelling adults with...
01/17/2011
First Report Managed Care
Feature
Drug-Eluting Stents as Safe as Bare-Metal Stents and More Effective in Large Coronary Arteries
01/17/2011
Chicago—Drug-eluting stents (sirolimus-eluting and everolimus-eluting) were found as safe as a baremetal stent in large arteries of patients with coronary heart disease in the BASKET-PROVE (Basel Stent Kosten-Effektivitäts Trial Prospective...
Chicago—Drug-eluting stents (sirolimus-eluting and everolimus-eluting) were found as safe as a baremetal stent in large arteries of patients with coronary heart disease in the BASKET-PROVE (Basel Stent Kosten-Effektivitäts Trial Prospective...
Chicago—Drug-eluting stents...
01/17/2011
First Report Managed Care
Feature
HeartWare LVAD Achieves Success in Clinical Trial of End-Stage Heart Failure
01/17/2011
Chicago—HeartWare (HeartWare International), an investigational left ventricular assist device (LVAD), was successful in treating patients with endstage heart failure as a bridge to transplantation, and it was noninferior compared with other...
Chicago—HeartWare (HeartWare International), an investigational left ventricular assist device (LVAD), was successful in treating patients with endstage heart failure as a bridge to transplantation, and it was noninferior compared with other...
Chicago—HeartWare (HeartWare...
01/17/2011
First Report Managed Care
Feature
STARFlex Closure of PFO Not Superior to Medical Therapy in Preventing Recurrent Stroke
01/17/2011
A study presented at the AHA meeting suggests that patent foramen ovale closure using the STARFlex septal repair implantable device is of no benefit in preventing recurrent stroke for the vast majority of patients who have sustained a...
A study presented at the AHA meeting suggests that patent foramen ovale closure using the STARFlex septal repair implantable device is of no benefit in preventing recurrent stroke for the vast majority of patients who have sustained a...
A study presented at the AHA...
01/17/2011
First Report Managed Care
Longer Sleep Duration per Night Associated with Increased Risk of Stroke in Older Women
01/17/2011
Research suggests that the risk of stroke is elevated in women who have more—not less—sleep. Women who slept ≥10 hours per night had a 63% increased risk of stroke compared with those who slept <7 hours per night in a substudy of the...
Research suggests that the risk of stroke is elevated in women who have more—not less—sleep. Women who slept ≥10 hours per night had a 63% increased risk of stroke compared with those who slept <7 hours per night in a substudy of the...
Research suggests that the risk...
01/17/2011
First Report Managed Care
Feature
Eplerenone Reduces Deaths and Hospitalizations in Mild Heart Failure
01/17/2011
Chicago—Eplerenone added to standard therapy for heart failure (HF) significantly reduced the risk of cardiovascular death or HF in patients with mild HF versus placebo. These findings of the EMPHASIS-HF (Eplerenone in Mild Patients...
Chicago—Eplerenone added to standard therapy for heart failure (HF) significantly reduced the risk of cardiovascular death or HF in patients with mild HF versus placebo. These findings of the EMPHASIS-HF (Eplerenone in Mild Patients...
Chicago—Eplerenone added to...
01/17/2011
First Report Managed Care
Feature
Warfarin Underused in Elderly Patients Undergoing Aortic Valve Replacement
01/17/2011
Chicago—Warfarin is used only in a minority of elderly patients after bioprosthetic aortic valve replacement (BVR) surgery, despite the fact that this procedure carries an early risk of thromboembolic events. Elderly patients undergoing BVR...
Chicago—Warfarin is used only in a minority of elderly patients after bioprosthetic aortic valve replacement (BVR) surgery, despite the fact that this procedure carries an early risk of thromboembolic events. Elderly patients undergoing BVR...
Chicago—Warfarin is used only in...
01/17/2011
First Report Managed Care
Feature
ROCKET AF: Rivaroxaban in Atrial Fibrillation
01/17/2011
Chicago—Rivaroxaban, an investigational antithrombotic drug, was found to be at least as effective as warfarin in patients with paroxysmal atrial fibrillation (AF), with fewer dangerous side effects, such as intracranial hemorrhage and fatal...
Chicago—Rivaroxaban, an investigational antithrombotic drug, was found to be at least as effective as warfarin in patients with paroxysmal atrial fibrillation (AF), with fewer dangerous side effects, such as intracranial hemorrhage and fatal...
Chicago—Rivaroxaban, an...
01/17/2011
First Report Managed Care
Feature
Prescription Fish Oil Fails to Prevent Recurrent Atrial Fibrillation
01/17/2011
Chicago—Fish oil (prescription omega-3 supplements, Lovaza) failed to prevent recurrence of atrial fibrillation (AF) compared with placebo in a randomized controlled trial reported at a late-breaking clinical trials session during the AHA...
Chicago—Fish oil (prescription omega-3 supplements, Lovaza) failed to prevent recurrence of atrial fibrillation (AF) compared with placebo in a randomized controlled trial reported at a late-breaking clinical trials session during the AHA...
Chicago—Fish oil (prescription...
01/17/2011
First Report Managed Care

Advertisement

Advertisement

Advertisement

FRMC Volume 21, Issue 3

Current Issue

September 2024
Volume 21
Issue 3
Current Issue
Issue Archive

Advertisement

Advertisement

What's Trending?

Conference Insider
Managing Chronic Kidney Disease in Older Adults
11/03/2014
Chronic kidney disease is pervasive in the older population. The progression of CKD can have a significant affect on the overall prognosis of a geriatric patient.
Chronic kidney disease is pervasive in the older population. The progression of CKD can have a significant affect on the overall prognosis of a geriatric patient.
Chronic kidney disease is...
11/03/2014
First Report Managed Care
News
Retirement, health insurance commonly targeted
08/04/2011
08/04/2011
First Report Managed Care
News
US Government Proposes More Transparency in Clinical Trials
11/19/2014
Health officials proposed significantly expanding what researchers are required to report about clinical trials of drugs, devices, and other interventions.
Health officials proposed significantly expanding what researchers are required to report about clinical trials of drugs, devices, and other interventions.
Health officials proposed...
11/19/2014
First Report Managed Care
News
Device Could Reduce Direct Medical Costs For Patients with COPD
11/15/2017
Recent research in the International Journal of COPD found that a handheld mechanical oscillating positive expiratory pressure device could significantly improve post-exacerbation care.
Recent research in the International Journal of COPD found that a handheld mechanical oscillating positive expiratory pressure device could significantly improve post-exacerbation care.
Recent research in...
11/15/2017
First Report Managed Care
News
Pelosi: Public option will not be in health bill despite liberal efforts
03/12/2010
03/12/2010
First Report Managed Care

Video Insights

Hayward
Videos
Evolving Health Care Contact Centers Into Drivers of Value-Based Care
07/31/2024
Discover how health care contact centers can transform into drivers of value-based care through AI, automation, upskilling agents, and rethinking workflows and metrics to improve patient outcomes and population health.
Discover how health care contact centers can transform into drivers of value-based care through AI, automation, upskilling agents, and rethinking workflows and metrics to improve patient outcomes and population health.
Discover how health care contact...
07/31/2024
First Report Managed Care
Lucille Accetta Headshot
Videos
Enhancing Patient Medication Adherence: Insights and Strategies From Asembia 2024
06/11/2024
Lucille Accetta, PharmD, MBA, MSPH, Senior Vice President of CVS Specialty Operations
Key stakeholders in the health care industry gathered to discuss prevalent topics at this year's Asembia annual summit. Medication adherence emerged as one of the most talked-about issues. In a session led by Lucille Accetta, PharmD, MBA,...
Key stakeholders in the health care industry gathered to discuss prevalent topics at this year's Asembia annual summit. Medication adherence emerged as one of the most talked-about issues. In a session led by Lucille Accetta, PharmD, MBA,...
Key stakeholders in the health...
06/11/2024
First Report Managed Care
Melissa Andel, Principal, CommonHealth Solutions, LLC
Videos
Navigating the Impact of the Inflation Reduction Act: Implications for Payers, Patients, and Manufacturers
05/24/2024
Melissa Andel, Principal, CommonHealth Solutions, LLC
Learn about the impacts of the Inflation Reduction Act on payers and patients, highlighting the changes in Medicare benefits and drug coverage coming in 2025 and 2026.
Learn about the impacts of the Inflation Reduction Act on payers and patients, highlighting the changes in Medicare benefits and drug coverage coming in 2025 and 2026.
Learn about the impacts of the...
05/24/2024
First Report Managed Care
Joe DePinto Headshot
Videos
Navigating Payment Models in the CGT Landscape: Insights and Innovations
05/21/2024
Joe DePinto, Head of Cell, Gene, and Advanced Therapies, McKesson
An expert discusses the evolution and challenges of payment models in the cell and gene therapy (CGT) space reviewed during his session at Asembia 2024.
An expert discusses the evolution and challenges of payment models in the cell and gene therapy (CGT) space reviewed during his session at Asembia 2024.
An expert discusses the...
05/21/2024
First Report Managed Care
Jennifer L. Mathieu Senior Vice President, Professional and Government Affairs at AMCP
Videos
Unlocking the Future of Managed Care Pharmacy: A Deep Dive into Federal Legislation and Regulations
05/15/2024
Jennifer L. Mathieu Senior Vice President, Professional and Government Affairs, AMCP
Learn about developments in federal legislation and regulations within the pharmacy landscape shaping the future of managed care in an interview with a session presenter from AMCP 2024.
Learn about developments in federal legislation and regulations within the pharmacy landscape shaping the future of managed care in an interview with a session presenter from AMCP 2024.
Learn about developments in...
05/15/2024
First Report Managed Care
Peter Martin, MD
Conference Coverage
Using Lenalidomide and Rituximab, Tazemetostat, or Bispecific Antibodies to Treat Patients With Follicular Lymphoma
04/06/2024

Featuring Peter Martin, MD

Featuring Peter Martin, MD
During the 2024 Great Debates & Updates in Hematologic Malignancies meeting in New York, Peter Martin, MD, argued in favor of alternative treatment regimens over CAR T-cell therapy for treating follicular lymphoma.
During the 2024 Great Debates & Updates in Hematologic Malignancies meeting in New York, Peter Martin, MD, argued in favor of alternative treatment regimens over CAR T-cell therapy for treating follicular lymphoma.
During the 2024 Great Debates &...
04/06/2024
Oncology
Tejaswi Kompala
Videos
Personalizing Weight Loss Management With GLP-1 Agonists
04/05/2024

Featuring Tejaswi Kompala, MD, head of cardiometabolic clinical strategy, Teladoc 

Featuring Tejaswi Kompala, MD, head o...
Delve into the rising demand for anti-obesity medications, the complexities of obesity management, and the importance of personalized approaches in improving cardiometabolic health in this insightful interview.
Delve into the rising demand for anti-obesity medications, the complexities of obesity management, and the importance of personalized approaches in improving cardiometabolic health in this insightful interview.
Delve into the rising demand for...
04/05/2024
First Report Managed Care
Zaubler Headshot
Videos
Integrating Behavioral Health Services to Reduce ED Visits: Substance Use Disorder and Social Determinants of Health
03/27/2024

Featuring Tom Zaubler, MD, MPH, CMO at NeuroFlow

Featuring Tom Zaubler, MD, MPH, CMO a...
Join us for the continuation of an engaging two-part series showcasing an expert dedicated to reducing emergency department visits through the integration of behavioral health practices. Dr Zaubler will share invaluable insights into...
Join us for the continuation of an engaging two-part series showcasing an expert dedicated to reducing emergency department visits through the integration of behavioral health practices. Dr Zaubler will share invaluable insights into...
Join us for the continuation of...
03/27/2024
First Report Managed Care
Zaubler Headshot
Videos
Integrating Behavioral Health Services to Reduce ED Visits: Suicide Prevention and Preemptive Primary Care
03/25/2024

Featuring Tom Zaubler, MD, MPH, CMO at NeuroFlow

Featuring Tom Zaubler, MD, MPH, CMO a...
Come join us for the first installment of a captivating two-part series featuring an expert committed to minimizing emergency department visits through the implementation of behavioral health integrations. Dr Zaubler will offer valuable...
Come join us for the first installment of a captivating two-part series featuring an expert committed to minimizing emergency department visits through the implementation of behavioral health integrations. Dr Zaubler will offer valuable...
Come join us for the first...
03/25/2024
First Report Managed Care
Yash Prajapati
Videos
Navigating the Evolution of Digital Solutions in Health Care
02/27/2024

Featuring Yash Prajapati, consultant at ZS Associates 

Featuring Yash Prajapati, consultant ...
Join us in exploring the challenges and opportunities in the development, approval, and integration of digital therapeutic solutions with ZS Associates consultant Yash Prajapati.
Join us in exploring the challenges and opportunities in the development, approval, and integration of digital therapeutic solutions with ZS Associates consultant Yash Prajapati.
Join us in exploring the...
02/27/2024
First Report Managed Care

Subscribe to our eNewsletters!

First Report Managed Care Newsletter

January 2011 Volume 8 Issue 1

View Issue Archive
Editorial Correspondence

Advertisement

Specialties

Events

Year Round Education

HMP Global Products

HMP Education Logo
HMP Omnimedia Logo
HMP Europe Logo
© 2024 HMP Global. All Rights Reserved.
Cookie Policy Privacy Policy Term of Use

Advertisement

Advertisement